Roche test offers one-hour heart attack diagnoses, study shows

Roche has published the findings of a new test showing how its cardiac troponin T high-sensitivity test can aid the rapid diagnoses of heart attacks.

Results from the TRAPID-AMI clinical study have been published online by the Annals of Emergency Medicine, with data collated from more than 1,200 patients with acute chest pain between 2011 and 2014.

Using Roche's test, the observation time needed to determine or rule out a heart attack can be reduced from between and three and six hours to just one hour, allowing treatment to be provided quicker and reducing the mortality risk.

The European Society of Cardiology has since adopted this new accelerated diagnostic concept, with their most recent clinical practice guidelines supporting the one-hour diagnostic algorithm validated by this study.

Roland Diggelmann, chief operating officer of Roche Diagnostics, said: "Results of the TRAPID-AMI study once again demonstrate how diagnostics can influence clinical practice to contribute to better patient outcomes."

This comes after the firm's Elecsys sFlt-1/PlGF immunoassay ratio test demonstrated its effectiveness in predicting preeclampsia in a study published earlier this month.